Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data

Diabetic Medicine ◽

10.1111/dme.13518 ◽

2017 ◽

Vol 34 (12) ◽

pp. 1728-1736 ◽

Author(s):

U. Anyanwagu ◽

J. Mamza ◽

J. Gordon ◽

R. Donnelly ◽

I. Idris

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Insulin Regimen ◽

Real World Data ◽

Randomized Controlled ◽

Bolus Insulin ◽

Download Full-text

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Diabetic Medicine ◽

10.1111/dme.12694 ◽

2015 ◽

Vol 32 (5) ◽

pp. 585-594 ◽

Author(s):

C. Wang ◽

J. Mamza ◽

I. Idris

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Insulin Regimen ◽

Randomized Controlled ◽

Bolus Insulin ◽

Download Full-text

2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)

Diabetes ◽

10.2337/db20-2192-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2192-PUB

Author(s):

STEWART B. HARRIS ◽

FRANK J. SNOEK ◽

LUIGI MENEGHINI ◽

FELIPE LAUAND ◽

JUKKA WESTERBACKA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Basal Insulin ◽

Treatment Satisfaction ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes

Diabetes Care ◽

10.2337/dc16-2725 ◽

2017 ◽

Vol 40 (11) ◽

pp. 1469-1478 ◽

Author(s):

Ginger S. Carls ◽

Edward Tuttle ◽

Ruo-Ding Tan ◽

Johnny Huynh ◽

John Yee ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

Review for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v1/review3 ◽

2020 ◽

Author(s):

Luigi Meneghini

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text

Author response for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v3/response1 ◽

2020 ◽

Author(s):

Dídac Mauricio ◽

Jukka Westerbacka ◽

Charlie Nicholls ◽

Jasmanda Wu ◽

Rishab Gupta ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Author Response ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text

Decision letter for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v3/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text

Review for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v2/review1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text

Decision letter for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text

Review for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v1/review2 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text

Decision letter for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text